Skip to main content Accessibility help
  • Print publication year: 2013
  • Online publication date: June 2014


Suggested reading

Faught E, Sachdeo RC, Remler MP, Chayasirisobhon S, Iraqui-Madoz VJ, Ramsay RE, Sutula TP, Kanner A, Harner RN, Kuzniecki R. Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology 1993; 43: 688–692.
French J, Smith M, Faught E, Brown L. The use of felbamate in the treatment of patients with intractable epilepsy: practice advisory. Neurology 1999; 52: 1540–1545.
Harden CL, Trifiletti R, Kutt H. Felbamate levels in patients with epilepsy. Epilepsia 1996; 37: 280–283.
Hurst DL, Rolan TD. The use of felbamate to treat infantile spasms. Journal of Child Neurology 1995; 10: 134–136.
Johannessen Landmark C, Patsalos PN. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Reviews in Neurotherapeutics 2010; 10: 119–140.
Kaufman DW, Kelly JP, Anderson T, Harmon DC, Shapiro S. Evaluation of case reports of aplastic anemia among patients treated with felbamate. Epilepsia 1997; 38: 1265–1269.
O’Neil MG, Perdun CS, Wilson MB, McGown ST, Patel S. Felbamate-associated fatal acute hepatic necrosis. Neurology 1996; 46: 1457–1459.
Patsalos PN. Antiepileptic drug interactions: a clinical guide, 2nd edition. 2013, Springer, London, UK; 2013.
Pellock JM, Faught E, Leppik IE, Shinnar S, Zupanc ML. Felbamate: consensus of current clinical experience. Epilepsy Research 2006; 71: 89–101.
The Felbamate Study Group in Lennox-Gastaut syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). New England Journal of Medicine 1993; 328: 29–33.
Zupanc ML, Roell Werner R, Schwabe MS, O’Connor SE, Marcuccilli CJ, Hecox KE, Chico MS, Eggener KA. Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Pediatric Neurology 2010; 42: 396–403.